ACE and lipoprotein glomerulopathy: RAS blocking agents have been employed for treating glomerulopathy in SCD patients; given the potential hypotensive effects of these drugs, we treated chimeric control and SCD mice (5-months old) with 25 mg/kg/day (gavage) enalapril, an ACE inhibitor, for 5 weeks.